J William L Brown

2.3k total citations
35 papers, 676 citations indexed

About

J William L Brown is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Neurology. According to data from OpenAlex, J William L Brown has authored 35 papers receiving a total of 676 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 8 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in J William L Brown's work include Multiple Sclerosis Research Studies (17 papers), Retinoids in leukemia and cellular processes (5 papers) and Peripheral Neuropathies and Disorders (4 papers). J William L Brown is often cited by papers focused on Multiple Sclerosis Research Studies (17 papers), Retinoids in leukemia and cellular processes (5 papers) and Peripheral Neuropathies and Disorders (4 papers). J William L Brown collaborates with scholars based in United Kingdom, Australia and United States. J William L Brown's co-authors include Alagaratnam Niruban, Chun Shing Kwok, Phyo Kyaw Myint, Yoon K. Loke, Alasdair Coles, Declan Chard, Matteo Pardini, Nicholas Lawn, Roberta Magliozzi and Richard Reynolds and has published in prestigious journals such as The Lancet, American Journal of Psychiatry and Brain.

In The Last Decade

J William L Brown

30 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J William L Brown United Kingdom 13 242 180 166 138 78 35 676
Tsutomu Oshima Japan 16 269 1.1× 101 0.6× 132 0.8× 256 1.9× 76 1.0× 47 1.0k
R. Pelayo Spain 10 302 1.2× 534 3.0× 183 1.1× 111 0.8× 326 4.2× 22 1.1k
Peter Lüdemann Germany 18 238 1.0× 52 0.3× 133 0.8× 149 1.1× 255 3.3× 36 832
S. Iglesias France 7 99 0.4× 150 0.8× 32 0.2× 132 1.0× 228 2.9× 9 705
Oleg Chernyshev United States 12 118 0.5× 54 0.3× 68 0.4× 270 2.0× 290 3.7× 38 776
Marcos Christiano Lange Brazil 14 165 0.7× 216 1.2× 23 0.1× 161 1.2× 156 2.0× 101 812
Bang-Ning Lee United States 5 122 0.5× 230 1.3× 152 0.9× 148 1.1× 14 0.2× 11 913
Mehmet Zarifoğlu Türkiye 21 281 1.2× 425 2.4× 51 0.3× 40 0.3× 237 3.0× 55 1.2k
U Gebhardt Germany 26 188 0.8× 72 0.4× 212 1.3× 24 0.2× 148 1.9× 55 1.9k
Laura Papetti Italy 21 253 1.0× 320 1.8× 107 0.6× 42 0.3× 426 5.5× 106 1.6k

Countries citing papers authored by J William L Brown

Since Specialization
Citations

This map shows the geographic impact of J William L Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J William L Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J William L Brown more than expected).

Fields of papers citing papers by J William L Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J William L Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J William L Brown. The network helps show where J William L Brown may publish in the future.

Co-authorship network of co-authors of J William L Brown

This figure shows the co-authorship network connecting the top 25 collaborators of J William L Brown. A scholar is included among the top collaborators of J William L Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J William L Brown. J William L Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dobson, Ruth, Karim L. Kreft, Benjamin M. Jacobs, et al.. (2025). Towards primary prevention of multiple sclerosis. Nature Reviews Neurology. 22(3). 182–195.
2.
McMurran, Christopher E, Jens Kühle, Alasdair Coles, et al.. (2025). Serum neurofilament light chain levels suggest neuroprotection following bexarotene-induced remyelination in people with relapsing remitting multiple sclerosis. Multiple Sclerosis and Related Disorders. 103. 106655–106655.
3.
McMurran, Christopher E, et al.. (2025). Ageing and remyelination failure in people with multiple sclerosis. Brain. 149(1). 48–58.
4.
McMurran, Christopher E, Ermelinda De Meo, Nick Cunniffe, et al.. (2024). Exploratory analysis of biological age measures in a remyelination clinical trial. Brain Communications. 7(1). fcaf032–fcaf032. 3 indexed citations
5.
Chen, Benson, et al.. (2024). Visual outcome measures in clinical trials of remyelinating drugs. BMJ Neurology Open. 6(1). e000560–e000560. 4 indexed citations
6.
Brown, J William L, Ferrán Prados, Daniel R. Altmann, et al.. (2022). Remyelination varies between and within lesions in multiple sclerosis following bexarotene. Annals of Clinical and Translational Neurology. 9(10). 1626–1642. 14 indexed citations
7.
Brown, J William L, Ferrán Prados, Baris Kanber, et al.. (2022). Retinoid-X receptor agonism promotes remyelination in relapsing-remitting multiple sclerosis: a phase 2 clinical trial. Journal of Neurology Neurosurgery & Psychiatry. 93(6). A92.3–A92. 2 indexed citations
8.
Hensiek, Anke, et al.. (2021). Clinician and patient experience of neurology telephone consultations during the COVID-19 pandemic. Postgraduate Medical Journal. 98(1161). 533–538. 4 indexed citations
9.
Rainbow, Daniel B., Lorna B. Jarvis, Nick Cunniffe, et al.. (2021). The MS Remyelinating Drug Bexarotene (an RXR Agonist) Promotes Induction of Human Tregs and Suppresses Th17 Differentiation In Vitro. Frontiers in Immunology. 12. 712241–712241. 16 indexed citations
10.
Brown, J William L, Ferrán Prados, Arman Eshaghi, et al.. (2019). Periventricular magnetisation transfer ratio abnormalities in multiple sclerosis improve after alemtuzumab. Multiple Sclerosis Journal. 26(9). 1093–1101. 9 indexed citations
11.
Brown, J William L, Baris Kanber, Ferrán Prados, et al.. (2019). Magnetisation transfer ratio abnormalities in primary and secondary progressive multiple sclerosis. Multiple Sclerosis Journal. 26(6). 679–687. 15 indexed citations
12.
Brown, J William L, Matteo Pardini, Wallace Brownlee, et al.. (2016). An abnormal periventricular magnetization transfer ratio gradient occurs early in multiple sclerosis. Brain. 140(2). 387–398. 59 indexed citations
13.
Brown, J William L & Declan Chard. (2015). The role of MRI in the evaluation of secondary progressive multiple sclerosis. Expert Review of Neurotherapeutics. 16(2). 157–171. 4 indexed citations
14.
Brown, J William L, Peter J. Martin, John Thorpe, et al.. (2014). Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis. Journal of Neuroimmunology. 271(1-2). 66–68. 26 indexed citations
15.
Brown, J William L, et al.. (2014). When is it safe to return to driving following first-ever seizure?. Journal of Neurology Neurosurgery & Psychiatry. 86(1). 60–64. 28 indexed citations
16.
Brown, J William L & Alasdair Coles. (2013). Alemtuzumab: evidence for its potential in relapsing–remitting multiple sclerosis. Drug Design Development and Therapy. 7. 131–131. 25 indexed citations
17.
Brown, J William L, Alasdair Coles, & Joanne Jones. (2013). First use of alemtuzumab in Balo’s concentric sclerosis: a case report. Multiple Sclerosis Journal. 19(12). 1673–1675. 10 indexed citations
18.
Brown, J William L, Yoon K. Loke, Chun Shing Kwok, Alagaratnam Niruban, & Phyo Kyaw Myint. (2013). ASSOCIATION OF OBSTRUCTIVE SLEEP APNOEA (OSA) WITH INCIDENT STROKE: A SYSTEMATIC REVIEW AND META–ANALYSIS. Journal of Neurology Neurosurgery & Psychiatry. 84(11). e2.192–e2. 2 indexed citations
19.
Brown, J William L, et al.. (2011). Amphetamine‐associated seizures: Clinical features and prognosis. Epilepsia. 52(2). 401–404. 20 indexed citations
20.
Brown, J William L. (1992). Screening infants for hearing loss--an economic evaluation.. Journal of Epidemiology & Community Health. 46(4). 350–356. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tsutomu Oshima Breakdown of academic impact, for papers by R. Pelayo Breakdown of academic impact, for papers by Peter Lüdemann Breakdown of academic impact, for papers by S. Iglesias Breakdown of academic impact, for papers by Oleg Chernyshev Breakdown of academic impact, for papers by Marcos Christiano Lange Breakdown of academic impact, for papers by Bang-Ning Lee Breakdown of academic impact, for papers by Mehmet Zarifoğlu Breakdown of academic impact, for papers by U Gebhardt Breakdown of academic impact, for papers by Laura Papetti
Rankless by CCL
2026